Business Standard

Torrent Pharma Q3 result: PBT rises 16% to Rs 319 crore, revenue declines

US business down by 22% in third quarter, India revenues grow by 5%

Pharma, medicine, drugs, Pharmaceuticals
Premium

Vinay Umarji Ahmedabad
Torrent Pharmaceuticals Ltd (TPL) saw its consolidated profit before tax (PBT) rise by 16 per cent on a year-on-year (YoY) basis to Rs 319 crore for the third quarter ended December 31, 2019, as per its BSE filing on Monday. 

In the corresponding Q3 of previous fiscal (2018-19), consolidated PBT for TPL stood at Rs 275 crore. The company saw its consolidated total revenue fall by 1.7 per cent on a YoY basis to Rs 2019 crore in Q3 of FY20 as against Rs 2054 crore recorded in Q3 of FY19.

Ranked eighth in Indian Pharmaceuticals Market (IPM) and amongst

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in